Journal article
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
- Abstract:
-
Background: Aspirin has been proposed as a treatment for COVID-19 on the basis of its anti-thrombotic properties. We aimed to evaluate the efficacy and safety of aspirin in patients admitted to hospital with COVID-19.
Methods: In this randomised, controlled, open-label, platform trial, several possible treatments were compared with usual care in patients hospitalised with COVID-19. The trial took place at 177 hospitals in the UK, two hospitals in I...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Bibliographic Details
- Publisher:
- Elsevier Publisher's website
- Journal:
- Lancet Journal website
- Volume:
- 399
- Issue:
- 10320
- Pages:
- 143-151
- Publication date:
- 2021-11-17
- Acceptance date:
- 2021-08-05
- DOI:
- EISSN:
-
1474-547X
- ISSN:
-
0140-6736
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
1190106
- Local pid:
- pubs:1190106
- Deposit date:
- 2021-08-09
Terms of use
- Copyright holder:
- Mafham et al.
- Copyright date:
- 2021
- Rights statement:
- © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
- Licence:
- CC Attribution (CC BY)
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record